Bradley L. Campbell, President and CEO at AMICUS THERAPEUTICS, INC. (FOLD), sold 81,092 shares at $14.23 ($1.1M) on 2024-01-02, disclosed to the SEC on 2024-01-04.
Scheduled sale ($1.1M) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.23 | 8,333 | $119K | 10.5% |
| 2 | $14.23 | 8,333 | $119K | 10.5% |
| 3 | $14.24 | 7,500 | $107K | 9.5% |
| 4 | $14.24 | 15,452 | $220K | 19.6% |
| 5 | $13.53 | 41,474 | $561K | 49.9% |
| Total | $13.87 avg | 81,092 |
| $1.1M |
| 100% |
| Filing → |
| FOLD | SELL | 2025-12-17 | $1.7M | — | Filing → |
| FOLD | SELL | 2025-12-03 | $292K | — | Filing → |
| FOLD | SELL | 2025-11-26 | $293K | — | Filing → |